1. Immunohistologic evidence of myocardial disease in apparently healthy relatives of patients with dilated cardiomyopathy.
- Author
-
Mahon NG, Madden BP, Caforio AL, Elliott PM, Haven AJ, Keogh BE, Davies MJ, and McKenna WJ
- Subjects
- Adult, Age Factors, Antigens, CD physiology, Antigens, Differentiation, Myelomonocytic physiology, Biopsy, CD3 Complex physiology, Cardiomyopathies metabolism, Cardiomyopathies pathology, Cardiomyopathy, Dilated metabolism, Cardiomyopathy, Dilated pathology, Endothelium, Vascular metabolism, Female, Fibrosis, Follow-Up Studies, HLA-DQ Antigens physiology, HLA-DR Antigens physiology, Humans, Hypertrophy, Left Ventricular metabolism, Hypertrophy, Left Ventricular pathology, Immunohistochemistry, Inflammation etiology, Inflammation metabolism, Intercellular Adhesion Molecule-1 physiology, Interpersonal Relations, London epidemiology, Male, Middle Aged, Reference Values, Cardiomyopathies diagnosis, Cardiomyopathy, Dilated diagnosis, Hypertrophy, Left Ventricular etiology
- Abstract
Objectives: This study investigated whether apparently healthy relatives of patients with idiopathic dilated cardiomyopathy (DCM) who have left ventricular enlargement (LVE) have biopsy evidence of underlying myocardial disease., Background: Left ventricular enlargement with normal systolic function is common among asymptomatic relatives of patients with DCM. Although there is circumstantial evidence to suggest that LVE may be a marker of early DCM, its pathophysiologic significance remains uncertain., Methods: Over six years, 767 asymptomatic relatives of 183 consecutive patients with DCM were evaluated: 37 (5%) had DCM and 104 (14%) had LVE (left ventricular end-diastolic dimension >112% predicted) with normal systolic function. Right ventricular biopsy was performed in 32 relatives with LVE, 14 patients with symptomatic DCM and 6 control subjects with normal ventricular function undergoing elective coronary artery bypass graft surgery. Histologic and immunohistochemical analyses, including quantitative double immunofluorescence, were performed for leukocyte markers (CD3 and CD68), intercellular adhesion molecule-1 (ICAM-1) and human leukocyte antigen class II antigens (DR and DQ)., Results: Histologic findings consistent with DCM were present in 50% of the patients with DCM, 25% of the relatives with LVE and 0% of the control subjects. The median CD3 count was 2.4/mm(2) in patients with DCM, 4/mm(2) in relatives with LVE and 0 in control subjects (p = 0.04). Using a threshold of >7 cells/mm(2), 21% of patients with DCM and 25% of relatives with LVE were CD3-positive (p = 0.01). Quantitative analysis demonstrated DR expression on 55.8+/-22.8%, 63.5+/-18.8% and 30.9+/-15.7% of the endothelial surface in patients with DCM, relatives and control subjects, respectively (p = 0.003). Corresponding values for ICAM expression were 35.6+/-15.1%, 36.7+/-14.5% and 17.3+/-7.9% (p = 0.013). When combining inflammatory and histologic changes, 28 (86%) of LVE, 14 (100%) of DCM and no control biopsies were abnormal (p < 0.001)., Conclusions: Most asymptomatic relatives of patients with DCM with LVE have histopathologic and immunopathologic findings similar to those of patients with established disease. Clinical identification and follow-up of such individuals are warranted to prevent presentation with advanced DCM and to enable assessment of interventions aimed at attenuating disease progression.
- Published
- 2002
- Full Text
- View/download PDF